Antibody Responses to Minor Histocompatibility Antigens After Solid Organ Transplantation. Issue 4 (1st October 2021)

• Record Type: Journal Article
• Authors: Zorn, Emmanuel; See, Sarah B.
• Is Part Of: Transplantation. Volume 106:Issue 4(2022)
• Page Start: 749
• Page End: 753
• Publication Date: 2021-10-01
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation immunology -- Periodicals; 617.95
• DOI: 10.1097/TP.0000000000003969
• Languages: English
• ISSNs: 0041-1337

Abstract

Abstract : Antibody-mediated rejection (AMR) is a major barrier to long-term graft survival following solid organ transplantation (SOT). Major histocompatibility antigens mismatched between donor and recipient are well-recognized targets of humoral alloimmunity in SOT and thought to drive most cases of AMR. In contrast, the implication of minor histocompatibility antigens (mHAs) in AMR has not been fully investigated, and their clinical relevance remains controversial. Recent technological advances, allowing for genome-wide comparisons between donors and recipients, have uncovered novel, polymorphic mHA targets with potential influence on the graft outcome following SOT. Here, we review these latest studies relating to mHAs and discuss their clinical significance.